News

May 14, 2008 - PLC Systems Inc. said it is demonstrating its RenalGuard System May 12-16 at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in Barcelona, Spain.

Home May 13, 2008
Home
Technology

Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.

Home May 13, 2008
Home
Feature | Maureen Leahy-Patano

Many formerly invasive diagnostic and interventional cardiology procedures have migrated to less invasive or percutaneous options. The subsequent rise in cath lab procedures has increased the need for alternatives to manual compression that promote hemostasis at the access site, allowing for quicker patient ambulation and throughput.

Home May 13, 2008
Home
News

May 14, 2008 - Broadlane clients, consisting of approximately 1,100 hospitals, selected ScImage for a three-year ...

Home May 13, 2008
Home
28603_1
Feature | Cristen C. Bolan

Atrial fibrillation (AF) affects more than 3.5 million Americans and is a major source of strokes and a precursor to ...

Home May 13, 2008
Home
News

May 13, 2008 - Boston Scientific reported that the FDA cleared its COGNIS cardiac resynchronization therapy ...

Home May 13, 2008
Home
News

May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...

Home May 13, 2008
Home
Technology

May 14, 2008 - St. Jude Medical received both FDA 510(k) clearance and European CE Mark approvals of the IsoFlex Optim pacing lead, small-diameter lead is built on the IsoFlex pacing lead platform, and features the company’s exclusive Optim insulation material.

Home May 13, 2008
Home
28601_1
Feature | Cristen C. Bolan

The most “wired” cardiology departments integrate IT systems, leverage data tracking and patient monitoring solutions, optimize data and image management for improved workflow, consult evidence-based medicine and plan for future enhancements to their infrastructure.

Home May 13, 2008
Home
News

May 14, 2008 - Siemens Healthcare will extend its strategic alliance with Biosense Webster by opening up the ACUSON ...

Home May 13, 2008
Home
28604_1
Feature | Richard R. Rogoski

Efforts to reduce discovery-to-balloon (d-to-b) and door-to-balloon times is sweeping the country as hospitals put in ...

Home May 13, 2008
Home
News

May 13, 2008 – The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT ...

Home May 12, 2008
Home
Technology

Boston Scientific's ALTRUA family of pacemakers is the first Boston Scientific-branded pacemaker to treat bradycardia ...

Home May 12, 2008
Home
Technology

Medtronic’s Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery disease. Endeavor uses the Driver bare metal cobalt alloy stent platform and the drug zotarolimus along with the proprietary, biocompatible drug delivery polymer.

Home May 12, 2008
Home
Technology

Edwards Lifesciences Corp. has rolled out a next-generation transfemoral delivery system for the Edwards SAPIEN ...

Home May 12, 2008
Home
Subscribe Now